Modulators of muscarinic receptors
The present invention relates to modulators of muscarinic receptors. The present invention also provides compositions comprising such modulators, and methods therewith for treating muscarinic receptor mediated diseases.
1. A compound selected from:
2. A pharmaceutical composition comprising a compound according to claim 1 and a pharmaceutical carrier.
3. A method of modulating activity of a muscarinic receptor, comprising the step of contacting said receptor with a compound selected from:
4. The method of claim 3 , wherein the compound selectively modulates the M 1 or M 4 muscarinic receptor.
5. A method of treating or reducing the severity of a disease or condition in a patient, wherein said disease or condition is selected from Attention Deficit Hyperactivity Disorder (ADHD), schizophrenia, pain, Parkinson's disease, and Glaucoma, wherein said method comprises the step of contacting said patient with a compound as described in claim 3 .